Posted by ABMN Staff on Apr 20th, 2024
10x Genomics (NASDAQ:TXG – Get Free Report) had its price target lowered by research analysts at Deutsche Bank Aktiengesellschaft from $60.00 to $55.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage...
More of this article »